Active ingredientOxitropium BromideCat. No. P-O061-001CAS 30286-75-0Family · Pharmaceutical analytical standards
Oxitropium
A semi-synthetic anticholinergic bronchodilator made from norscopolamine, a natural alkaloid: patented in 1966 and approved in 1983, it is used in asthma and chronic obstructive pulmonary disease (COPD). This family brings together the active ingredient and pharmacopoeial impurities.
Did you know?Crystals of its bromide salt are thermosalient: when heated or cooled they can literally jump, a rare phenomenon that fascinates crystallographers.
Go to the active ingredient →Active ingredientOxitropium BromideCat. No. P-O061-001CAS 30286-75-0
Pharmacopoeial impurityOxitropium Bromide EP Impurity DCat. No. P-O061-002CAS 95778-01-1No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Reference substanceOxitropium bromide CRSEDQM code Y0000709Family Oxitropium
ImpurityOxitropium bromide impurity B CRSEDQM code Y0000715Family OxitropiumImpurityOxitropium bromide impurity D CRSEDQM code Y0000713Family OxitropiumNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.